Rani Therapeutics Holdings, Inc.
RANI
$1.39
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.52% | 2.93% | 9.92% | 11.63% | 21.00% |
| Total Depreciation and Amortization | -0.91% | 7.17% | 16.89% | 25.06% | 28.61% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 95.87% | 84.64% | 73.30% | 61.72% | 44.51% |
| Change in Net Operating Assets | 93.84% | 79.16% | -17.17% | 74.58% | -214.81% |
| Cash from Operations | 29.64% | 31.41% | 29.37% | 30.72% | 26.35% |
| Capital Expenditure | 70.54% | 67.81% | 69.87% | 78.19% | 74.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.16% | -36.09% | -24.26% | -35.42% | 74.74% |
| Cash from Investing | -13.41% | -35.52% | -23.00% | -33.66% | 89.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 55.76% | 4,998.04% | 5,022.40% | 4,899.75% | 2,380.33% |
| Repurchase of Common Stock | -23.68% | -1.89% | -84.21% | 70.99% | 76.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.08% | -- | -- | -- | -634.87% |
| Cash from Financing | -86.77% | 2,302.95% | 2,713.01% | 5,730.47% | -46.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.86% | 287.69% | 126.71% | 90.06% | 96.88% |